TABLE 2.
NF-κB inhibition by HHV-8 genes
Analytical method | Gene
|
NF-κB inhibition
|
P value | ||
---|---|---|---|---|---|
Activating | Inhibitory | Fca | Rangeb | ||
RTCM | LMP-1 | K14 | 0.50 | 0.22-1.62 | 0.01 |
K10.5 | 0.48 | 0.28-1.39 | 0.01 | ||
K9 | 0.41 | 0.18-2.09 | 0.01 | ||
K1 | 0.38 | 0.26-1.25 | 0.01 | ||
Classical transfection | LMP-1 | K14 | 0.41 | 0.35-0.49 | 0.001 |
K1 | 0.35 | 0.32-0.39 | 0.001 | ||
K9 | 0.27 | 0.21-0.31 | 0.001 | ||
K10.5 | 0.17 | 0.14-0.20 | 0.001 | ||
K13 | K9 | 0.65 | 0.61-0.69 | 0.001 | |
K14 | 0.62 | 0.58-0.65 | 0.001 | ||
K10.5 | 0.48 | 0.44-0.50 | 0.001 | ||
K1 | 0.40 | 0.37-0.43 | 0.001 |
The fc values were determined in comparison to those for transfections with the activator (the LMP-1 gene or K13) alone. The threshold for significant inhibition of LMP-1 gene- or K13-induced NF-κB activation was set to an fc of ≤0.50 and a P value of ≤0.05.
RTCM results were obtained for 38 replications.